Total Payments
$280,371
2024 Payments
$75,334
Companies
69
Transactions
1,935
Medicare Patients
667
Medicare Billing
$43,841
Payment Breakdown by Category
Other$182,805 (65.2%)
Food & Beverage$48,187 (17.2%)
Travel$37,194 (13.3%)
Consulting$12,031 (4.3%)
Education$154.55 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $177,705 | 106 | 63.4% |
| Food and Beverage | $48,187 | 1,592 | 17.2% |
| Travel and Lodging | $37,194 | 213 | 13.3% |
| Consulting Fee | $12,031 | 6 | 4.3% |
| Honoraria | $5,100 | 11 | 1.8% |
| Education | $154.55 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biohaven Pharmaceuticals, Inc. | $57,270 | 150 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $55,375 | 159 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $30,969 | 81 | $0 (2022) |
| IDORSIA PHARMACEUTICALS US INC | $23,772 | 55 | $0 (2024) |
| PFIZER INC. | $17,804 | 190 | $0 (2024) |
| GlaxoSmithKline, LLC. | $15,147 | 42 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $14,013 | 43 | $0 (2024) |
| CeQur Corporation | $13,098 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $6,932 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $6,626 | 154 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75,334 | 275 | Otsuka America Pharmaceutical, Inc. ($29,270) |
| 2023 | $79,305 | 270 | Otsuka America Pharmaceutical, Inc. ($25,733) |
| 2022 | $41,750 | 241 | Biohaven Pharmaceutical Holding Company Ltd. ($30,969) |
| 2021 | $61,847 | 321 | Biohaven Pharmaceuticals, Inc. ($57,163) |
| 2020 | $3,118 | 164 | AstraZeneca Pharmaceuticals LP ($405.77) |
| 2019 | $7,102 | 207 | AstraZeneca Pharmaceuticals LP ($1,625) |
| 2018 | $6,386 | 210 | AstraZeneca Pharmaceuticals LP ($1,305) |
| 2017 | $5,530 | 247 | AstraZeneca Pharmaceuticals LP ($1,353) |
All Payment Transactions
1,935 individual payment records from CMS Open Payments — Page 1 of 78
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $7.29 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $5.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: Neuropsychiatry | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.05 | General |
| Category: DIABETES | ||||||
| 12/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.01 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,120.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $120.44 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $113.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $78.12 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $109.08 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Biological | ||||||
| 11/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.93 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $12.60 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $152.76 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 140 | 194 | $19,658 | $12,251 |
| 2022 | 4 | 143 | 194 | $16,416 | $10,098 |
| 2021 | 5 | 194 | 240 | $19,790 | $12,636 |
| 2020 | 6 | 190 | 224 | $14,762 | $8,857 |
Total Patients
667
Total Services
852
Medicare Billing
$43,841
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 114 | $10,633 | $6,604 | 62.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 60 | $7,852 | $5,154 | 65.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 20 | $1,172 | $493.93 | 42.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 77 | $7,389 | $4,559 | 61.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 32 | $4,327 | $3,004 | 69.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 47 | 68 | $4,163 | $2,004 | 48.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 17 | 17 | $537.03 | $531.08 | 98.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 75 | 110 | $10,242 | $6,274 | 61.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 53 | $7,031 | $4,289 | 61.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 24 | 27 | $1,594 | $1,145 | 71.9% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 25 | 25 | $479.25 | $479.25 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 25 | 25 | $443.75 | $448.75 | 101.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 35 | 46 | $5,271 | $3,298 | 62.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 52 | 70 | $5,522 | $2,959 | 53.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 24 | 27 | $2,138 | $1,000 | 46.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 36 | 37 | $674.75 | $653.15 | 96.8% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 31 | 32 | $600.06 | $596.46 | 99.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 12 | $555.90 | $349.55 | 62.9% |
About Dr. Xu He, D.O
Dr. Xu He, D.O is a Internal Medicine healthcare provider based in Redlands, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2010. The National Provider Identifier (NPI) number assigned to this provider is 1568773448.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Xu He, D.O has received a total of $280,371 in payments from pharmaceutical and medical device companies, with $75,334 received in 2024. These payments were reported across 1,935 transactions from 69 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($177,705).
As a Medicare-enrolled provider, He has provided services to 667 Medicare beneficiaries, totaling 852 services with total Medicare billing of $43,841. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Redlands, CA
- Active Since 06/25/2010
- Last Updated 01/05/2026
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1568773448
Products in Payments
- NURTEC ODT (Drug) $103,087
- REXULTI (Drug) $56,292
- QUVIVIQ (Drug) $23,772
- VOQUEZNA (Drug) $14,013
- AREXVY (Drug) $13,432
- CeQur Simplicity (Device) $13,098
- Kerendia (Drug) $6,932
- ImmunoCAP (Device) $5,389
- Zypitamag (Drug) $4,652
- FARXIGA (Drug) $3,007
- JARDIANCE (Drug) $2,479
- KRYSTEXXA (Biological) $2,114
- VRAYLAR (Drug) $1,138
- SOLIQUA (Drug) $1,050
- SOLIQUA 100/33 (Biological) $1,018
- Ozempic (Drug) $993.66
- AFREZZA (Drug) $918.43
- ELIQUIS (Drug) $788.63
- XARELTO (Drug) $770.22
- UBRELVY (Drug) $762.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Redlands
Islam Abudayyeh, M.d, M.D
Internal Medicine — Payments: $128,597
Internal Medicine $128,597
Mohitkumar Ardeshana, M.d, M.D
Internal Medicine — Payments: $9,080
Internal Medicine $9,080
George Saffouri, Md, MD
Internal Medicine — Payments: $8,326
Internal Medicine $8,326
Rimon Shaker, Md, MD
Internal Medicine — Payments: $5,178
Internal Medicine $5,178
Dr. Balram Khehra, Md, MD
Internal Medicine — Payments: $4,970
Internal Medicine $4,970
Mrs. Katrina Platt, D.o, D.O
Internal Medicine — Payments: $4,424
Internal Medicine $4,424